NL7301936A - - Google Patents

Info

Publication number
NL7301936A
NL7301936A NL7301936A NL7301936A NL7301936A NL 7301936 A NL7301936 A NL 7301936A NL 7301936 A NL7301936 A NL 7301936A NL 7301936 A NL7301936 A NL 7301936A NL 7301936 A NL7301936 A NL 7301936A
Authority
NL
Netherlands
Application number
NL7301936A
Other versions
NL179026C (nl
NL179026B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7301936A publication Critical patent/NL7301936A/xx
Publication of NL179026B publication Critical patent/NL179026B/xx
Application granted granted Critical
Publication of NL179026C publication Critical patent/NL179026C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NLAANVRAGE7301936,A 1972-03-01 1973-02-12 Werkwijze ter bereiding van een geneesmiddel met als actieve verbinding een 2-alkylamino 4'-methyl 4-piperazino-5-thiopyrimidineverbinding en werkwijze voor de bereiding van de actieve verbinding. NL179026C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7206981A FR2173746B1 (xx) 1972-03-01 1972-03-01

Publications (3)

Publication Number Publication Date
NL7301936A true NL7301936A (xx) 1973-09-04
NL179026B NL179026B (nl) 1986-02-03
NL179026C NL179026C (nl) 1986-07-01

Family

ID=9094373

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7301936,A NL179026C (nl) 1972-03-01 1973-02-12 Werkwijze ter bereiding van een geneesmiddel met als actieve verbinding een 2-alkylamino 4'-methyl 4-piperazino-5-thiopyrimidineverbinding en werkwijze voor de bereiding van de actieve verbinding.

Country Status (14)

Country Link
US (1) US3843656A (xx)
JP (1) JPS5416510B2 (xx)
AR (1) AR195597A1 (xx)
BE (1) BE796114A (xx)
CA (1) CA977756A (xx)
CH (1) CH556858A (xx)
DE (1) DE2307536C3 (xx)
DK (1) DK130978B (xx)
ES (1) ES412182A1 (xx)
FR (1) FR2173746B1 (xx)
GB (1) GB1363047A (xx)
NL (1) NL179026C (xx)
NO (1) NO137236C (xx)
SE (1) SE398750B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2281117A2 (fr) * 1974-08-09 1976-03-05 Ugine Kuhlmann Nouvelles piperazino-pyrimidines utilisables comme medicaments
US4166852A (en) * 1974-08-09 1979-09-04 Produits Chimiques Ugine Kuhlmann Piperazino-pyrimidines and their use as spasmolytic agents
NL7605319A (nl) * 1975-05-23 1976-11-25 Mar Pha Etu Expl Marques Werkwijze ter bereiding van een geneesmiddel, zo gevormd geneesmiddel en werkwijze ter bereiding van geschikte geneeskrachtige verbindingen.
FR2417507A2 (fr) * 1977-07-28 1979-09-14 Ugine Kuhlmann Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides
FR2503162A1 (fr) * 1981-04-07 1982-10-08 Pharmindustrie Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments
JPS6039175U (ja) * 1983-08-26 1985-03-18 沖電気工業株式会社 発券プリンタのスタツカ装置
DE3417264A1 (de) * 1984-05-10 1985-11-14 Bayer Ag, 5090 Leverkusen Neue 2,4-diamino-6-halogen-5-alkylthio-pyrimidine
WO1996031488A1 (fr) * 1995-04-03 1996-10-10 Sumitomo Pharmaceuticals Company, Limited Nouveaux derives de pyrimidine efficaces en tant que medicament psychotrope et leur procede de fabrication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB951431A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
US3843656A (en) 1974-10-22
NO137236C (no) 1978-01-25
FR2173746B1 (xx) 1975-04-25
SE398750B (sv) 1978-01-16
JPS4899185A (xx) 1973-12-15
GB1363047A (en) 1974-08-14
NL179026C (nl) 1986-07-01
DE2307536C3 (de) 1980-03-06
DK130978C (xx) 1975-10-13
BE796114A (fr) 1973-08-28
DE2307536B2 (de) 1979-06-28
CH556858A (fr) 1974-12-13
JPS5416510B2 (xx) 1979-06-22
FR2173746A1 (xx) 1973-10-12
CA977756A (en) 1975-11-11
NO137236B (no) 1977-10-17
ES412182A1 (es) 1976-01-01
AR195597A1 (es) 1973-10-23
DK130978B (da) 1975-05-12
DE2307536A1 (de) 1973-09-13
NL179026B (nl) 1986-02-03

Similar Documents

Publication Publication Date Title
FR2176933A1 (xx)
FR2173746B1 (xx)
FR2194561B1 (xx)
JPS4933579A (xx)
JPS49843U (xx)
FR2184290A5 (xx)
JPS4983322A (xx)
JPS4927471A (xx)
JPS5138805Y2 (xx)
JPS4999394U (xx)
JPS4962998U (xx)
JPS4979669U (xx)
JPS4990648A (xx)
CH589589A5 (xx)
CH565893A (xx)
CH563481A5 (xx)
CH587805A5 (xx)
CH565842A5 (xx)
SE7200207L (xx)
NL7314572A (xx)
CH583002A5 (xx)
CH563634A5 (xx)
CH567361A5 (xx)
CH563296A5 (xx)
CH567381A5 (xx)

Legal Events

Date Code Title Description
BC A request for examination has been filed
A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee